Search for: "BRISTOL-MYERS SQUIBB" Results 641 - 660 of 863
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV challenge: Meda… [read post]
24 Mar 2010, 9:11 am by Evan Schaeffer
Since May 2004, Pfizer, Eli Lilly, Bristol-Myers Squibb and four other drug companies have paid a total of $7 billion in fines and penalties. [read post]
24 Mar 2010, 4:45 am
(Patent Docs) Reyataz (Atazanavir): US: Patent infringement complaint filed following a Paragraph IV certification: Bristol-Myers Squibb Co. et al. v. [read post]
23 Mar 2010, 10:49 am
Plavix (clopidogrel), the anti-clotting drug sold by Bristol-Myers Squibb and Sanofi-Aventis SA will now get the FDA's most serious black box warning, Reuters reported earlier this month. [read post]
23 Mar 2010, 10:49 am
Plavix (clopidogrel), the anti-clotting drug sold by Bristol-Myers Squibb and Sanofi-Aventis SA will now get the FDA's most serious black box warning, Reuters reported earlier this month. [read post]
19 Mar 2010, 7:45 am by Carey, Danis & Lowe
If Bristol-Myers Squibb and Sanofi-Aventis knew of these problems and did not warn doctors and patients appropriately, they could be held responsible for harm suffered by patients who took their drug. [read post]
19 Mar 2010, 1:22 am
Solomon, who co-chaired Proskauer's litigation practice until last year, will bring with him a roster of clients, including PepsiCo, Bristol-Myers Squibb and AriZona Iced Tea. [read post]
12 Mar 2010, 4:06 pm by Mark Zamora
Source:http://www.webmd.com/heart-disease/news/20100312/new-plavix-warning-lack-of-effect-in-gene-carriersAs far back as November 23, 1998 the Federal Drug Administration (FDA) expressed its concern with the claims made by the drug manufacturer, Bristol-Myers Squibb/Sanofi Pharmaceuticals about Plavix. [read post]
8 Mar 2010, 7:49 am by Broc Romanek
., Eastman Chemical, Safeway, Dow Chemical, Pfizer, Chevron, Bristol-Myers Squibb, and Time Warner. [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog)   Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog)   Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
28 Feb 2010, 3:17 pm by Christopher T. Hurley
The Food and Drug Administration says, “an organ transplant drug from Bristol-Myers Squibb improves kidney function, but the agency has concerns about potentially fatal side effects. [read post]
27 Feb 2010, 6:24 am by Lawrence B. Ebert
Cir. 1992); Bristol-Myers Squibb Co. v. [read post]
17 Feb 2010, 4:55 pm by Sheppard Mullin
Several years later, two of Abbott's competitors (GSK and Bristol-Myers Squibb) introduced two new PIs which were meant to be used in conjunction with booster quantities of Norvir. [read post]
16 Feb 2010, 4:31 am by Broc Romanek
In addition, Time Warner, Genzyme, Bristol-Myers Squibb, International Paper, Pinnacle West Capital, and Liz Claiborne Inc. have filed similar no-action requests to exclude proposals with a 10 percent threshold, according to investors. [read post]
9 Feb 2010, 7:59 am by David J. Clark
§1832, from his employer Bristol-Myers-Squibb, where he worked from November 2007 through February 2, 2010. [read post]
4 Feb 2010, 7:31 am
Jhaveri, a native of India, was a Technical Operations Associate with Bristol-Myers-Squibb for a little over two years until he was fired. [read post]
4 Feb 2010, 7:31 am
Jhaveri, a native of India, was a Technical Operations Associate with Bristol-Myers-Squibb for a little over two years until he was fired." [read post]